MedTrace Logo

Cardiogenomics Registry

NCT00861575 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2601

Last updated 2017-11-20

No results posted yet for this study

Summary

This is a continuous blood banking study that will archive plasma and blood permitting DNA and plasma analysis at a future date. Subjects are recruited at the time of a clinically required procedure and blood samples are collected and banked and used for future research. The main purpose of this study is to investigate the interaction of multiple phenotypes and genotypes and their impact on cardiovascular disease events and measures of atherosclerosis progression.

Conditions

Sponsors & Collaborators

  • Piedmont Healthcare

    lead OTHER

Principal Investigators

  • Sarah Rinehart, MD · Piedmont Healthcare

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00861575 on ClinicalTrials.gov